"The understanding of the endocannabinoid system is rapidly expanding, and so is the need for endocannabinoid support products. We're so excited here at Emerson to offer a cannabis-free herbal option for practitioners and patients who would like alternatives to CBD,” said Jaclyn Chasse, ND, vice president of medical education & Wellevate at Emerson.
“We understand the excitement generated by the growing category of endocannabinoid health and wanted to create a line that goes beyond CBD by offering practitioners and their patients the health support results they may be looking for, but with a more comprehensive and targeted approach. Our relationship with Emerson allows thousands of practitioners to offer our products to their patients with the confidence of knowing they are safe, legal, and effective,” says Jade Beutler, CEO at Emerald.
Emerald’s science-backed line addresses patients’ five most common health concerns—sleep, healthy inflammation, occasional anxiety, mood, and cognition— with a powerful blend of cannabis-free herbs and botanicals that demonstrate a broad, powerful “entourage effect” on the endocannabinoid system according to a recent in vitro study. Plus, the line is drug test and DSHEA (Dietary Supplement Health and Education Act) compliant, vegan, and gluten-free.